Mattia Boeri

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori

Affiliated withFondazione IRCCS Istituto Nazionale dei Tumori

Research Area

Biography

Mattia Boeri has not added Biography.
If you are Mattia Boeri and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 34	2017

Other Publications

Article	Year
Prognostic determinants in epithelioid sarcoma. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 20932739	2011
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21300873	2011
Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer journal (Sudbury, Mass.)\| PubMed ID: 22647364	2012
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 24419137	2014
Assessment of circulating microRNAs in plasma of lung cancer patients. Molecules (Basel, Switzerland)\| PubMed ID: 24619302	2014
Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery\| PubMed ID: 24623168	2014
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]. Journal of the National Cancer Institute\| PubMed ID: 24652652	2014
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes. Oncotarget\| PubMed ID: 24810989	2014
Therapeutic use of microRNAs in lung cancer. BioMed research international\| PubMed ID: 25309923	2014
Corrigendum to 'Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know'. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery\| PubMed ID: 25694655	2015
Potential biomarkers for lung cancer screening. Translational lung cancer research\| PubMed ID: 25806293	2014
Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging. Expert review of molecular diagnostics\| PubMed ID: 25924864	2015
Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations. EBioMedicine\| PubMed ID: 26425689	2015
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening. Oncotarget\| PubMed ID: 26451608	2015
Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 26921675	2016
[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test]. Epidemiologia e prevenzione\| PubMed ID: 26951732	2016
MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature. Microarrays (Basel, Switzerland)\| PubMed ID: 27600084	2016
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 28302568	2017
Inflammatory status and lung function predict mortality in lung cancer screening participants. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)\| PubMed ID: 28333763	2017
Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 28472743	2017
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness. Scientific reports\| PubMed ID: 28751748	2017